All Takayuki Hoshii (Professor at Chiba University) articles

  • SETD1B_Figures_R2_20250426TH_SI_ver8
    News

    Disabling the SETD1B enzyme halts leukaemia cell growth

    2025-07-02T13:30:47Z

    Japanese researchers have identified the epigenetic enzyme SETD1B as a key driver of aggressive acute myeloid leukaemia (AML) – which could lead to new treatment strategies targeting the cancer’s underlying biology in the future.